In conclusion, we have shown that EPO when expressed in supra-physiological levels has substantial metabolic effects including protection against diet-induced obesity and normalisation of glucose sensitivity associated with a shift to increased fat metabolism in the muscles. This evidence concerns the gene EPO and obesity due to melanocortin 4 receptor deficiency.